Access cutting-edge non-small cell lung cancer treatment through this clinical trial at a research site in Walnut Creek. Study-provided care at no cost to qualified participants.
Access non-small cell lung cancer specialists in Walnut Creek at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-small cell lung cancer treatment provided free
The purpose of this study is to evaluate sacituzumab tirumotecan versus pemetrexed in combination with carboplatin for the treatment of epidermal growth factor receptor (EGFR)-mutated advanced non-squamous non-small cell lung cancer (NSCLC). Participants in this study have NSCLC that has continued to progress on prior treatment with EGFR tyrosine kinase inhibitors (TKIs). The primary hypotheses of this study are that sacituzumab tirumotecan is better than platinum-based doublet chemotherapy (pe
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this non-small cell lung cancer clinical trial in Walnut Creek, CA
If you're searching for non-small cell lung cancer treatment options in Walnut Creek, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Walnut Creek research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.